RIVN - XM CFMS and PROG among pre market gainers
Kezar Life Sciences (NASDAQ:KZR) +46% on phase 2 data for lupus candidate Axon Enterprise (NASDAQ:AXON) +24% on Q3 results Cyclo Therapeutics (NASDAQ:CYTH) +19% on Q3 results. Comstock Holding Companies (NASDAQ:CHCI) +20% on Q3 results. Romeo Power (NYSE:RMO) +14% on Q3 results Creatd (NASDAQ:CRTD) +13% on Q3 results Progenity (NASDAQ:PROG) +13%. PLBY Group (NASDAQ:PLBY) +12% on Q3 results Rackspace Technology (NASDAQ:RXT) +11% on Q3 results. GSE Systems (NASDAQ:GVP) +7% on Q3 results On Holding AG (NYSE:ONON) +8% on Q3 results Lottery.com (NASDAQ:LTRY) +8% on Q3 results. RIVIAN AUTOMOTIVE (NASDAQ:RIVN) +9% races to another new high as Amazon and Ford sit on big gains Royalty Pharma (NASDAQ:RPRX) +8% Warren Buffett's Berkshire Hathaway adds Royalty Pharma, exits Merck Aptinyx (NASDAQ:APTX) +8%. Xcel Brands (NASDAQ:XELB) +8% on Q3 results. Hyzon Motors (NASDAQ:HYZN) +7% Soros takes new stakes in Hyzon, Hill-Rom; exits Clarivate, Otis Worldwide Conformis (NASDAQ:CFMS) +7%. QIAGEN N.V. (NYSE:QGEN) +7% amid rumors of fresh takeover bid 360 DigiTech (NASDAQ:QFIN) +7% on Q3 results. Lucid Group (NASDAQ:LCID) +6% points to accelerating demand as production ramp progresses Qualtrics International (NASDAQ:XM) +6%. Vodafone Group Plc (NASDAQ:VOD) +6% on 1H results. AMMO (NASDAQ:POWW) +6% on
For further details see:
XM, CFMS and PROG among pre market gainers